Skip to content
★ Sign in to follow
SG

Steven Glazer

Idogen AB
Total declarations
2
Company
1
▲ Purchases (2 ops.)
€12k
▼ Sales (0 ops.)
—

Latest filing published 12 Dec 2018 for Idogen AB, €6,553.

Filing timeline

BuySale
Steven Glazer

Insider track record

Disclosed buys
2
Disclosed sells
0
Signal history

No signal scores available.

Closed purchases

Market purchases
2

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

Steven Glazer: trading record in brief

Steven Glazer discloses dealings in Idogen AB to Finansinspektionen. Over a trading history stretching from 16 June 2017 to 5 December 2018, the count stands at 2 filings.

Purchases make up the whole of the open-market record (2 purchases, €12k). Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. So far in 2018, the count stands at 1 purchase and no sales.

The record was last updated on 12 December 2018 with an open-market purchase (€6,553) in Idogen AB. This summary is built from Finansinspektionen disclosures alone and does not predict where the share price will go.

Companies and markets linked to Steven Glazer

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations2 total
  • ▲
    Chief Medical Officer, IdogenABExecutivesIdogen AB
    67,078 SEK0FI-SE
    38,330 shares@ SEK 1.7555.9% of flowBTA (betald tecknad aktie)ISIN SE0011896786FI:csv-bae856a8ff19f77e7818
    Canonical exit: 5 Mar 2019 (T+90)
  • ▲
    CMO, IdogenExecutivesIdogen AB
    50,400 SEK30FI-SE
    1,200 shares@ SEK 42.0044.1% of flowISIN SE0009973308FI:csv-20c26103bbf2def934d1
    Canonical exit: 14 Sept 2017 (T+90)

2 of 2 declarations